Follow
SNV - Oncology panels
A single nucleotide variants (SNV) describe genetic alterations occurring in a single nucleotide (adenine [A], thymine [T], cytosine [C], or guanine [G]). When a SVP occurs in more than 1% of a population it is known as a single nucleotide polymorphism (SNP). Oncology panels that screen for SNVs in a patient's tumor to aid in optimizing personalized treatment options.
OCT 21, 2020 | 10:15 PM
Comprehensive genomic profiling in clinical studies helps to detect clinically relevant cancer driver mutations using low amount of tumor tissues within several days. Recent studies have sho...
APR 21, 2020 | 12:00 PM
Within the clinical arena, the oncology community has led the way in the early adoption of next generation sequencing. NGS is in widespread use in clinical cancer research and is now beginni...
APR 10, 2019 | 10:30 AM
The BRCA1 and BRCA2 genes represent the best examples of the modern understanding of cancer molecular genetics. Testing for germline and somatic mutations in BRCA 1/2 has gradually become com...
APR 06, 2016 | 1:30 PM
Cancer remains the second leading cause of death in the United States. Most tumors arise from a myriad of genetic changes that dysregulate cell growth and prompt survival. Ident...
APR 10, 2019 | 10:30 AM
The BRCA1 and BRCA2 genes represent the best examples of the modern understanding of cancer molecular genetics. Testing for germline and somatic mutations in BRCA 1/2 has gradually become com...
APR 06, 2016 | 1:30 PM
Cancer remains the second leading cause of death in the United States. Most tumors arise from a myriad of genetic changes that dysregulate cell growth and prompt survival. Ident...